Delivery Order SPE2DR25D1202-SPE2DR26F71ZM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $2,628.24 to AmerisourceBergen Drug Corp for RECTIV 0.4% Ointment (30 grams) on August 4, 2025, with an ultimate completion date of August 5, 2025. This non-set-aside, competitively awarded contract is structured as a firm fixed price delivery order and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,207.91 to AmerisourceBergen Drug Corp on September 4, 2025, for Rectiv 0.4% Ointment in 30-gram units. This is a firm fixed price delivery order with no set-aside designation, with an ultimate completion date of September 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for Rectiv 0.4% Ointment in 30-gram units, with a firm fixed price ceiling value of $1,570.88 and an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,822.00 to AmerisourceBergen Drug Corp for the supply of Rectiv 0.4% Ointment in 30-gram units. This non-set-aside contract was competitively awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The firm fixed price delivery order represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,219.76 to AmerisourceBergen Drug Corp for Rectiv 0.4% Ointment in a 30-gram quantity. The contract was competitively awarded without a set-aside designation and utilizes firm fixed pricing. This delivery order was completed on April 23, 2025, one day after the award date of April 22, 2025. The product will be performed and sourced from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 30, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram units. This is a firm fixed-price delivery order with a ceiling value of $1,927.00, with an ultimate completion date of June 2, 2025. The contract carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania served as the place of performance. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 15, 2025, for Rectiv 0.4% Ointment in 30-gram quantities, with a ceiling value of $3,515.21. This firm fixed-price delivery order, which will be completed by May 16, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract was competitively awarded with no set-aside designation, and performance will occur at...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram units. This is a firm fixed price contract with a ceiling value of $1,668.99 and an ultimate completion date of July 21, 2025. The contract was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Rectiv 0.4% Ointment in 30-gram units. This firm fixed-price delivery order, valued at $2,833.45, was competitively awarded without a set-aside designation and carries an ultimate completion date of September 17, 2025. The place of performance is located at AmerisourceBergen's corporate office in...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Rectiv 0.4% Ointment in 30-gram quantities, with a ceiling value of $2,518.06 and an ultimate completion date of September 5, 2025. This non-set-aside competitive award represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F71ZMDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $4,691.24 to AmerisourceBergen Drug Corp for RECTIV 0.4% Ointment in a 30-gram formulation on November 6, 2025, with final completion scheduled for November 7, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical vendor, fulfills this order through its substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This delivery order represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare systems under the DLA's comprehensive pharmaceutical supply vehicle. AmerisourceBergen Drug Corp's extensive federal contract portfolio demonstrates its capability to deliver a broad range of pharmaceutical products and medical supplies through open competition, including specialty medications, vaccines, and generic drugs across multiple therapeutic domains. The award reflects the company's established role as a primary vendor within the federal medical supply chain for military and veteran healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 11/6/25 |